Canton Strategic Holdings, Inc. (CNTN)
2.57
+0.26
(+11.26%)
USD |
NASDAQ |
Sep 25, 16:00
2.70
+0.13
(+5.06%)
After-Hours: 06:18
Canton Strategic Holdings Enterprise Value : 161.35M for Sept. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 161.35M |
| September 24, 2026 | 141.26M |
| September 23, 2026 | 135.85M |
| September 22, 2026 | 152.08M |
| September 21, 2026 | 151.30M |
| September 18, 2026 | 140.49M |
| September 17, 2026 | 125.03M |
| September 16, 2026 | 120.40M |
| September 15, 2026 | 120.78M |
| September 14, 2026 | 125.03M |
| September 11, 2026 | 125.80M |
| September 10, 2026 | 128.90M |
| September 09, 2026 | 133.53M |
| September 08, 2026 | 135.08M |
| September 04, 2026 | 138.94M |
| September 03, 2026 | 136.62M |
| September 02, 2026 | 123.49M |
| September 01, 2026 | 138.94M |
| August 31, 2026 | 138.94M |
| August 28, 2026 | 134.30M |
| August 27, 2026 | 144.35M |
| August 26, 2026 | 135.08M |
| August 25, 2026 | 141.26M |
| August 24, 2026 | 128.12M |
| August 21, 2026 | 131.99M |
| Date | Value |
|---|---|
| August 20, 2026 | 133.53M |
| August 19, 2026 | 124.26M |
| August 18, 2026 | 118.08M |
| August 17, 2026 | 119.24M |
| August 14, 2026 | 118.85M |
| August 13, 2026 | 114.99M |
| August 12, 2026 | 114.99M |
| August 11, 2026 | 109.58M |
| August 10, 2026 | 107.26M |
| August 07, 2026 | 107.26M |
| August 06, 2026 | 106.49M |
| August 05, 2026 | 109.58M |
| August 04, 2026 | 110.35M |
| August 03, 2026 | 117.30M |
| July 31, 2026 | 111.90M |
| July 30, 2026 | 105.71M |
| July 29, 2026 | 111.90M |
| July 28, 2026 | 120.40M |
| July 27, 2026 | 119.62M |
| July 24, 2026 | 112.67M |
| July 23, 2026 | 121.94M |
| July 22, 2026 | 124.26M |
| July 21, 2026 | 129.67M |
| July 20, 2026 | 121.17M |
| July 17, 2026 | 140.49M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.078B |
| Oncolytics Biotech, Inc. | 81.50M |
| Sangamo Therapeutics, Inc. | 51.40M |
| Sarepta Therapeutics, Inc. | 2.229B |
| Anixa Biosciences, Inc. | 81.18M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.95M |
| Revenue (Quarterly) | 1.496M |
| Total Expenses (Quarterly) | 19.45M |
| EPS Diluted (Quarterly) | -0.0888 |
| Profit Margin (Quarterly) | -1.20K% |
| Earnings Yield | -56.27% |
| Normalized Earnings Yield | -35.17 |